PURPOSE: To evaluate the serial hemodynamic changes that occur after transcatheter arterial embolization (TAE) of hepatocellular carcinomas (HCCs). MATERIALS AND METHODS: Twenty patients with HCCs treated with TAE were evaluated with color and duplex Doppler sonography before, immediately after, and 2 days after TAE. The changes in hepatic artery and portal vein velocity and flow were evaluated. RESULTS: The portal venous velocity and flow did not change significantly after TAE. The peak systolic velocity in the proximal hepatic artery decreased significantly (P < .01) immediately after TAE then returned to baseline values 2 days after TAE; the resistance index of the proximal hepatic artery increased significantly (P < .01) immediately after embolization, then returned to baseline values 2 days after TAE. Arterial signal in the distal hepatic artery, generally absent immediately after TAE, could be recorded 2 days after. CONCLUSION: There is a rapidly reversible decrease in hepatic arterial flow induced by embolization, without any change in portal venous flow.
PURPOSE: To evaluate the serial hemodynamic changes that occur after transcatheter arterial embolization (TAE) of hepatocellular carcinomas (HCCs). MATERIALS AND METHODS: Twenty patients with HCCs treated with TAE were evaluated with color and duplex Doppler sonography before, immediately after, and 2 days after TAE. The changes in hepatic artery and portal vein velocity and flow were evaluated. RESULTS: The portal venous velocity and flow did not change significantly after TAE. The peak systolic velocity in the proximal hepatic artery decreased significantly (P < .01) immediately after TAE then returned to baseline values 2 days after TAE; the resistance index of the proximal hepatic artery increased significantly (P < .01) immediately after embolization, then returned to baseline values 2 days after TAE. Arterial signal in the distal hepatic artery, generally absent immediately after TAE, could be recorded 2 days after. CONCLUSION: There is a rapidly reversible decrease in hepatic arterial flow induced by embolization, without any change in portal venous flow.
Authors: S Bianco; C Merkel; S Savastano; S Bellon; M Chiesura-Corona; M Bolognesi; D Miotto; E Enzo; G Feltrin; A Gatta Journal: Gut Date: 1996-08 Impact factor: 23.059
Authors: F W Winkelbauer; B Nierderle; O Graf; R Prokesch; S Thurnher; R Wildling; J Lammer Journal: Cardiovasc Intervent Radiol Date: 1995 Nov-Dec Impact factor: 2.740
Authors: Alexander F Hagel; Wolfgang H Hagel; Annette S Lindner; Ferdinand J Kammerer; Markus F Neurath; Peter C Konturek; Igor A Harsch Journal: Med Sci Monit Date: 2011-08
Authors: Bernhard Scheiner; Gregor Ulbrich; Mattias Mandorfer; Thomas Reiberger; Christian Müller; Fredrik Waneck; Michael Trauner; Claus Kölblinger; Arnulf Ferlitsch; Wolfgang Sieghart; Markus Peck-Radosavljevic; Matthias Pinter Journal: United European Gastroenterol J Date: 2019-03-21 Impact factor: 4.623
Authors: Constantine Frangakis; Jae Ho Sohn; Ahmet Bas; Julius Chapiro; Ruediger E Schernthaner; MingDe Lin; James P Hamilton; Timothy M Pawlik; Kelvin Hong; Rafael Duran Journal: Front Oncol Date: 2021-11-05 Impact factor: 6.244